Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease.

[1]  P. Rehak,et al.  Transesophageal Echocardiography for Quantifying Size of Patent Foramen Ovale in Patients With Cryptogenic Cerebrovascular Events , 2002, Stroke.

[2]  Spirometric predictors for the exclusion of severe hypoxemia in chronic obstructive pulmonary disease. , 2001, Canadian respiratory journal.

[3]  P. Touboul,et al.  Is Patent Foramen Ovale a Family Trait?: A Transcranial Doppler Sonographic Study , 2001, Stroke.

[4]  B. Celli,et al.  Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[5]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[6]  J G Miller,et al.  Contrast Echocardiography: Current and Future Applications , 2000 .

[7]  H. Sahebjami,et al.  Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[8]  D. Russell,et al.  Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  P. Raggi,et al.  Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. , 1998, Chest.

[10]  M. Tischler,et al.  Prevalence of pulmonary hypertension in limited and diffuse scleroderma. , 1996, Chest.

[11]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[12]  E. Fisher,et al.  The incidence of patent foramen ovale in 1,000 consecutive patients. A contrast transesophageal echocardiography study. , 1995, Chest.

[13]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[14]  S. Rich,et al.  The prevalence and significance of a patent foramen ovale in pulmonary hypertension. , 1993, Chest.

[15]  J. Bugler,et al.  Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. , 1993, Thorax.

[16]  M. Kotler,et al.  Patent foramen ovale: a nonfunctional embryological remnant or a potential cause of significant pathology? , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  R. Marshall,et al.  PARADOXICAL SYSTEMIC EMBOLISATION THROUGH A PATENT FORAMEN OVALE , 1989, The Lancet.

[18]  T. Yoshioka,et al.  [Prognosis of primary pulmonary hypertension and its determinants]. , 1988, Journal of cardiology.

[19]  E. Robin,et al.  PRIMARY PULMONARY HYPERTENSION , 2022 .

[20]  C. Oakley,et al.  Factors that influence the outcome of primary pulmonary hypertension. , 1986, British heart journal.

[21]  L. Wann,et al.  Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. , 1984, The American journal of cardiology.

[22]  W. Edwards,et al.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. , 1984, Mayo Clinic proceedings.